Pharmacology & ToxicologybioRxiv
Rational Design and Synthesis of Selective PRMT4 Inhibitors: a New Chemotype for Development of Cancer Therapeutics
M. Sutherland, A. Li, A. Kaghad…·V. Santhakumar
This study designs and synthesizes a new class of selective PRMT4 inhibitors with improved selectivity over other PRMT family members.
DOI 10.1002/cmdc.202100018